Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. Net Income 2010–2024
Eterna Therapeutics Inc. annual/quarterly net income history and growth rate from 2010 to 2024. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Eterna Therapeutics Inc. net income for the quarter ending September 30, 2024 was -26.6 M, a 375.84% increase year-over-year.
- Eterna Therapeutics Inc. net income for the twelve months ending September 30, 2024 was -44.4 M, a 164.34% increase year-over-year.
- Eterna Therapeutics Inc. annual net income for 2024 was -44.5 M, a 105.55% increase from 2023.
- Eterna Therapeutics Inc. annual net income for 2023 was -21.7 M, a 11.84% decrease from 2022.
- Eterna Therapeutics Inc. annual net income for 2022 was -24.6 M, a 237.11% increase from 2020.
- Eterna Therapeutics Inc. annual net income for 2020 was -7.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eterna Therapeutics Inc. Net Income — FAQ
Eterna Therapeutics Inc. (ERNA) net income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Eterna Therapeutics Inc.'s net income?
Eterna Therapeutics Inc. (ERNA) reported net income of -$45M for fiscal 2024.
Where can I see ERNA's net income history?
The chart and table above show Eterna Therapeutics Inc.'s net income by year and by quarter, including the growth rate.